Clinical Trial: Loteprednol Etabonate Versus Prednisolone Acetate for Anterior Chamber Granulomas

U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT07496060) titled 'Loteprednol Etabonate Versus Prednisolone Acetate for Anterior Chamber Granulomas' on March 22.

Brief Summary: The goal of this clinical trial is to compare the efficacy and safety of two different topical corticosteroids in 66 pediatric patients with active anterior chamber granuloma.

The main questions it aims to answer are:

* Does Loteprednol Etabonate 1% provide equivalent inflammation control and granuloma resolution compared to Prednisolone Acetate 1% over a 3-month period?

* Does Loteprednol Etabonate 1% result in a lower frequency of steroid-related intraocular pressure (IOP) elevations than Prednisolone Acetate 1%? Rese...